AzTrials
AzTrials

Rapid Sequence InductionEUROpE-RSINCT02751684

EUROpE-RSI (EURopean Online Evaluation RSI Study)

An observational study of Rapid Sequence Induction, run by Universitätsklinikum Köln at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Europe. Read more about this study

Who is it for?
Ages 25 to 70 years
Conditions the study is for
Rapid Sequence Induction
How many people
1,500 participants
Where
1 siteGermany
Study dates
1 Mar 2017to 31 May 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Emergency physicians from europe; e.g. members of the European Society of Anaestesiology

Who may be able to join

  • Emergency physician

Who cannot join

  • None Emergency physician

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University hospital of Cologne

    Cologne, North Rhine-Westphalia, 50935

Other trials in Germany

About this study

Official title: EUROpE RSI-Study (EURopean Online Evaluation) - Pan-european Online-survey About Rapid Sequence Induction (RSI) by Anesthetists

The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Europe.

Read the detailed description

The study is designed as a web-based online survey for anaesthetist in Europe. They will be invited via mail, as members of the European Society of Anaesthesiology (ESA), the participation is voluntary.

The survey contains 30 items about the standards and procedures of in-hospital rapid sequence induction (RSI). There will be a selection of possible answers, only a few items contains free-text answers.

The study collects only personal data to age, country, gender and level of training.

The collected data should identify differences in the procedures of RSI.

Keywords
Rapid Sequence Induction, European, Evaluation, EUROpE RSI, Standards, RSI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in the procedure of the RSI (Rapid sequence induction)

    The questionnaire date will be collected up to 6 month and processed with Microsoft Excel.

    Measured: 04.30.2016-10.30.2016

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2016 (estimated)
  2. Study start1 Mar 2017
  3. Primary completion31 May 2017
  4. Study completion31 May 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
1,500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02751684
Sponsor's protocol ID
UKoln
Acronym
EUROpE-RSI
Status last verified
Apr 2019
First submitted
11 Apr 2016
Last updated
4 Apr 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Rapid Sequence Induction, run by Universitätsklinikum Köln at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in the procedure of the RSI (Rapid sequence induction) (time frame: 04.30.2016-10.30.2016). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in